Intended for healthcare professionals

Spironolactone use and renal toxicity: population based longitudinal analysis

Li Wei, Allan D Struthers, Tom Fahey, Alexander D Watson, Thomas M MacDonald
DOI: 10.1136/bmj.c1768 Published 18 May 2010
Figure1

Fig 1 Spironolactone prescriptions (top) and prescribing rates (bottom) for different indications in Tayside population between 1994 and 2007. HF=heart failure; LC=liver cirrhosis

Vol 377 Issue 8338 Table of Contents
BMJ:

Subjects